Ignite Creation Date:
2025-12-25 @ 2:26 AM
Ignite Modification Date:
2026-02-24 @ 2:08 PM
Study NCT ID:
NCT02509234
Status:
UNKNOWN
Last Update Posted:
2015-07-27
First Post:
2015-07-01
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trabectedin and Irinotecan for Refractory Pediatric Sarcomas
Sponsor:
Technical University of Munich
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TrI.PReSarc V150429
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None